Micro Emerging Active

RSV vaccine re-vaccination trial results

Score
0.2
Velocity
▲ 0.0
Articles
1
Sources
1

Summary

An article belongs to this narrative if it discusses the Phase I clinical trial results of Clover Biopharmaceuticals' RSV PreF vaccine candidate.

Related Articles

Clover Biopharmaceuticals Reports Positive U.S. Phase I Data On RSV Re-Vaccination In Older Adults

Nasdaq · Mar 25, 2026
Mixed

Sources

Clover Biopharmaceuticals Reports Positive U.S. Phase I Data On RSV … Nasdaq

Timeline

Last Updated Mar 25, 2026